Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

GILD    AMGN    BIIB    CELG    Benchmark  United States  NYSE  11,117   58.12  0.53% 

Collecting data for STEM

StemCells Inc  





Year To Date
Last 1 Month(s)
10 Days Price Trend
April 21, 2015 
Highest Price  
Lowest Price  
March 19, 2015 
April 20, 2015 

StemCells Market Sensitivity

As returns on market increase, StemCells returns are expected to increase less than the market. However during bear market, the loss on holding StemCells will be expected to be smaller as well.

StemCells Inc Market Cap Over Time

NameStemCells Inc
InstrumentUSA Stock
Contact Number510. 456. 4000
CurrencyUSD - US Dollar
ExchangeNasdaq Capital Markets
DescriptionStemCells, Inc., a biopharmaceutical company, researches, develops, and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more
Return On Asset(52.23) %
Price to Book11.88 times
Price to Sales69.12 times

StemCells agains markets

 United States Nasdaq   1.27 % Macroaxis: change 1.27 Moved Up  
 United States Russel   1.04 % Macroaxis: change 1.0433 Moved Up  
 United States SP 500   0.92 % Macroaxis: 0.92 Moved Up  
 United States NYSE   0.53 % Macroaxis: 0.53 Moved Up  
 thisRed STEM STEM agains markets  2.00 % Macroaxis: change 2.0 Moved Down  
Compare to Competition   Compare Correlations

StemCells Leadership

Martin McGlynn CEO, CEO of Stemcells California Inc and President of Stemcells California Inc, Director and Member of Strategic Transactions Committee
John Schwartz Independent Chairman of the Board, Ph.D

StemCells Diversification Suggestion

Use StemCells to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of StemCells to be traded at $0.865 in 30 days

StemCells Price and Market Media

The median price of StemCells for the period between Sun, Mar 22, 2015 and Tue, Apr 21, 2015 is 0.99 with a coefficient of variation of 4.54. The daily time series for the period is distributed with a sample standard deviation of 0.04, arithmetic mean of 0.98, and mean deviation of 0.03. The Stock received some media coverage during the period.
StemCells Value 
Benchmark  Embed   Timeline 
Stocks Attain Market Attention GlaxoSmithKline plc StemCells...04/17/2015

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 69.15 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 69.29 M outstanding shares of which 1.97 M shares are at this time shorted by private and institutional investors with about 2.8 trading days to cover.

StemCells Inc Accumulated Other Comprehensive Income Over Time

StemCells Alerts

StemCells Inc generates negative expected return over the last 30 days
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 1.01 M. Net Loss for the year was (32.26 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 24.99 M in cash with (27.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Stocks Attain Market Attention GlaxoSmithKline plc StemCells Inc ...

StemCells Earnings Estimates

StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Earnings Estimate  

StemCells Research Report

Get StemCells research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells report to view

StemCells Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run pair correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing theme could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alan Trounson Director

StemCells Fundamentals Correlation

Net Income vs Current Liabilities
Market Capitalization vs Current Asset
Net Income vs Current Ratio

StemCells vs Competition

StemCells vs. Gilead Sciences Inc
StemCells vs. Amgen Inc
StemCells vs. Biogen Idec Inc
StemCells vs. Celgene Corporation
StemCells vs. Regeneron Pharmaceuticals Inc
StemCells vs. Alexion Pharmaceuticals Inc
StemCells vs. Vertex Pharmaceuticals Incorporated
StemCells vs. Illumina Inc
StemCells vs. Pharmacyclics Inc
StemCells vs. BioMarin Pharmaceutical Inc

StemCells April 21, 2015 Opportunity Range

Information Ratio(0.33)
Maximum Drawdown8.04
Value At Risk(4.00)